ArticleMolecules (Basel, Switzerland)2022

New Quinoxaline-Based Derivatives as PARP-1 Inhibitors: Design, Synthesis, Antiproliferative, and Computational Studies.

Yasmin M Syam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.